SAB Biotherapeutics, Inc.

NASDAQ:SABS

Biotechnology

Healthcare
$2.91 -0.53%

-$0.02 today

Market cap
$262.16M
Beta
0.53
P/E (TTM)
3.0
EPS (TTM)
-$0.16
52W Low $1.85High $5.15

Volume 1.75M

Average 0.76M

Price history

SAB Biotherapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-23.42%

Period high

$4.59

Period low

$2.49

Latest

$2.91

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 5, 2026Nov 5, 2026
25-NSEOct 22, 2026Oct 22, 2026
8-KOct 13, 2026Oct 13, 2026
4Sep 18, 2026Sep 18, 2026
424B3Aug 21, 2026Aug 21, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 12, 2026Aug 12, 2026
SC 13D/AAug 10, 2026Aug 10, 2026
10-QAug 6, 2026Aug 6, 2026
8-KJul 7, 2026Jul 7, 2026

Competitors

Who does SAB Biotherapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about SABS's filings, answered from its disclosures.

What is the latest SABS filing?

The latest filing shown is 10-Q dated Nov 5, 2026.

How many recent filings does SABS have?

Intrinsic Alpha currently shows 20 recent filings for SABS.